polarean Share News (POLX)

Polarean Imaging partners with Vida Diagnostics on MRI solutions

(Alliance News) - Polarean Imaging PLC on Friday said that it has partnered with Vida Diagnostics Inc to work on advanced magnetic resonance imaging solutions for the lungs.

TRADING UPDATES: Polarean withdraws commercial targets on revenue drop

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

IN BRIEF: Polarean Imaging announces code price range for Xenoview

Polarean Imaging PLC - London-based medical imaging technology developer - Announces that following statement on August 29, the reimbursement code for the Polarean Xenoview technology has been assigned to a new technology ambulatory payment classification code which corresponds to a payment range of between USD1,201 to USD1,300 as part of the 2023 medicare hospital outpatient prospective payment system final rule. Notes the codes enables healthcare providers a path to bill for "magnetic resonance imaging with inhaled hyperpolarised xenon-129 contrast agent, chest, including preparation and administration of agent."

UK earnings, trading statements calendar - next 7 days

Polarean's Xenoview gets US reimbursement code

(Sharecast News) - Medical device developer Polarean Imaging announced on Tuesday that its Xenoview technology has been granted a new reimbursement code by the US Centers for Medicare and Medicaid Services (CMS).

IN BRIEF: Polarean Imaging product cleared for US Medicare payments

Polarean Imaging PLC - London-based medical imaging technology developer - Says the US Centers for Medicare & Medicaid Services has established a new reimbursement code for Polarean's Xenoview or 'xenon XE 129' magnetic resonance imaging technology. Code "enables healthcare providers a path to bill for 'magnetic resonance imaging with [the] inhaled hyperpolarised xenon-129 contrast agent...including preparation and administration of agent'." Polarean expects to be informed of the new code's payment level "in the coming weeks".

IN BRIEF: Polarean hails US FDA approval on Philips MRI configuration

Polarean Imaging PLC - London-based medical imaging technology company - Receives 510(k) clearance from the US Food & Drug Administration for its specialised magnetic resonance imaging chest coil. The coil may now include Philips 3.0T MRI scanners for the visualisation of the Xenon-129 nuclei.

TRADING UPDATES: Touchstone wells shut in, Trident quarter receipts up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Wednesday and not separately reported by Alliance News:

UK shareholder meetings calendar - next 7 days

IN BRIEF: Polarean hires new CEO as Richard Hullihen retires

Polarean Imaging PLC - London-based medical imaging technology company - Hires Brainsway Chief Executive Officer Christopher von Jako as new CEO. Says he will be succeeding CEO Richard Hullihen, who will be retiring after seven years in the role, and will also be stepping down as director of the company immediately.

Polarean shares jump after unveiling collaboration with Philips

(Alliance News) - Polarean Imaging PLC shares jumped on Friday after it unveiled a collaboration with Philips to advance the field of hyperpolarised Xenon MRI.

Polarean shares down despite narrowed annual loss and optimism

(Alliance News) - Polarean Imaging PLC shares were down on Friday despite slimming its annual loss, as the company said it now will focus on gaining commercial traction and exploring further financing for its newly US Food & Drug Administration-approved Xenoview device.

TRADING UPDATES: Capital Metals to appeal Sri Lanka mining suspension

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: